Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2682-2689

  Mrena, S ^a   Savola, K ^b   Kulmala, P ^b   Reijonen, H ^c   Ilonen, J ^c   Akerblom H K ^a   Knip, Mikael ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN;

ADOLESCENT; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DNA MODIFICATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING;

EID: 0038305480     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020644     Document Type: Article

References (28)

1. Degnbol B, Green A 1978 Diabetes mellitus among first- and second-degree relatives of early onset diabetics. Ann Hum Genet 42:25-34
2. Dahlquist G, Blom L, Holmgren G, Hagglof B, Larsson Y, Sterky G, Wall S 1985 The epidemiology of diabetes in Swedish children 0-14 years: a six-year prospective study. Diabetologia 28:802-808
3. Veijola R, Reijonen H, Vähäsalo P, Sabbah E, Kulmala P, Ilonen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group 1996 HLA-QB1-defined genetic susceptibility, β-cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. J Clin Invest 98:2489-2495
4. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EA 1988 Predicting insulin-dependent diabetes. Lancet 1:845-850
5. Bingley PJ, Bonifacio E, Gale EAM 1993 Can we really predict IDDM? Diabetes 42:213-220
6. Lorenzen T, Pociot F, Hougaard P, Nerup J 1994 Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 37:321-327
7. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Åkerblom HK, the Childhood Diabetes in Finland Study Group 1992 Epidemiology of childhood diabetes mellitus in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70-76
8. Somersalo O 1955 Studies of childhood diabetes. Incidence in Finland. Ann Paediatr Fenn 1:239-249
9. EURODIAB ACE Study Group 2000 Variation and trends in incidence of childhood diabetes in Europe. Lancet 355:873-876
10. WHO Study Group 1980 Diabetes mellitus. WHO Tech Rep Ser 727:10-12
11. Bottazzo GF, Florin-Christensen A, Doniach D 1974 Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279-1282
12. Lernmark Å, Molenaar JL, Van Beers WA, Yamaguchi Y, Nagataki S, Ludvigsson J, MacLaren NK 1991 The fourth international serum exchange workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 34:534-535
13. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WA, MacLAren NK, Lernmark Å 1992 Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 41:1570-1574
14. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL 1983 Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339
15. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T 1994 Detection of GAD(65) antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467
16. Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group 1996 Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 81:2455-2459
17. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS 1998 Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes 47:1857-1866
18. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group 1998 IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 41:424-429
19. Herbert V, Lau KS, Gottlieb CW, Bleicher SW 1965 Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384
20. Hjelm M 1966 Enzymatic determination of hexoses in blood and urine. Scand J Clin Lab Invest Suppl 18:85-98
21. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner IS, Eisenbarth GS 1984 Pre-type 1 diabetes. Linear loss of β-cell response to intravenous glucose. Diabetes 33:717-720
22. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, the Childhood Diabetes in Finland Study Group 1989 New susceptibility haplotype for type 1 diabetes. Lancet ii:299-302
23. 1984 Nomenclature for factors of the HLA system. In: Albert ED, Mayr WR, eds. Histocompatibility testing. Berlin: Springer-Verlag; 4-8
24. Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T 1995 Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870-877
25. Ilonen J, Reijonen H, Herva E, Sjöroos M, Itiä A, Lövgren T, Veijola R, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group 1996 Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 19:795-800
26. Kulmala P, Savola K, Reijonen H, Veijola R. Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Ilonen J, Tuomilehto J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group 2000 Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes m siblings of affected children. Diabetes 49:48-58
27. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A, Francois R, Herz G, New M, Schober E 1986 HLA-DR3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29:207-210
28. Mrena S, Savola K, Kulmala P, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group 1999 Staging of preclinical type 1 diabetes in siblings of affected children. Pediatrics 104:925-930